Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Genmab
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Canadian Cancer Trials Group
University of California, Davis
M.D. Anderson Cancer Center
University of Cologne
St. Jude Children's Research Hospital
University Hospital Southampton NHS Foundation Trust
University of Miami
University of Washington
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
International Extranodal Lymphoma Study Group (IELSG)
ADC Therapeutics S.A.
Memorial Sloan Kettering Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
University of Nebraska
University of Wisconsin, Madison
M.D. Anderson Cancer Center
University of Cincinnati
University of Birmingham
University of California, Davis
M.D. Anderson Cancer Center
University of Washington
The First Affiliated Hospital with Nanjing Medical University
SCRI Development Innovations, LLC
National Institutes of Health Clinical Center (CC)
Spectrum Pharmaceuticals, Inc
Universität des Saarlandes
Jonsson Comprehensive Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
University of Wisconsin, Madison
University of Maryland, Baltimore
University of Miami
Seagen Inc.
Barbara Ann Karmanos Cancer Institute
Seagen Inc.
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oncology Specialists, S.C.
Lymphoma Study Association